Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗
XELB CEO Robert Loren buys 81,466 shares at $1.16; stock down 77.9% from 52-week high but up 49.2% in 30 days.
CEO D Loren Robert W purchased 81,466 shares at $1.16 on 2025-12-17, increasing his holdings by 13.4% to 687,297 shares. This marks his second buy in two weeks—he also purchased on 2025-12-05—following a sharp 49.2% recovery over the past 30 days after the stock fell 77.9% from its 52-week high of $5.42. His prior two transactions at XELB were both well-timed at the 90-day mark (returns of +1061.5% and +14.6%), establishing a pattern of successful entry timing at this ticker. However, the company faces significant headwinds: revenue of $1.1M last quarter with net income of -$7.9M, annual revenue contraction of 53.5%, and unprofitability over the most recent full fiscal year, indicating the buy occurs in a deeply distressed business environment despite favorable near-term price momentum.
Director DiSanto bought 50,000 XELB shares at $0.35; stock down -85.8% from 52-week high of $6.85 amid -53.5% revenue decline and -$7.9M net loss.
Director Mark DiSanto acquired 50,000 shares at $0.35 on 2025-12-05, increasing his holdings by 17.4% to 337,018 shares. This marks his third open-market purchase at XELB; his prior two buys at this ticker generated 90-day returns of +14.6% and +985.1%, both well-timed based on subsequent price movement. However, the current transaction occurs in a sharply deteriorated operating context: the company posted revenue of $1.1M against a net loss of $-7.9M in the latest quarter, with full-year annual revenue down -53.5% and the stock trading -85.8% below its 52-week high of $6.85. The $0.97 current price reflects a -17.1% decline over 30 days and -34.0% over 90 days—a material drawdown from the $0.35 purchase price. While DiSanto's cross-ticker track record shows strong prior execution (100% 90-day win rate, averaging +499.8% return), his same-ticker history at XELB demonstrates timing skill, yet the fundamental deterioration (unprofitable, sharply declining revenue) and ongoing share-price weakness warrant caution about whether historical timing patterns remain predictive in this altered environment.
CEO Robert Loren buys 50,000 XELB shares at $0.35; stock down -85.8% from 52-week high, -34.0% in 90 days.
CEO and Chairman Robert Loren purchased 50,000 shares of XCel Brands at $0.35 on 2025-12-05, increasing his holdings by 9.0% to 605.8K shares. The purchase occurs amid severe stock deterioration: XELB trades at $0.97, down -85.8% from its 52-week high of $6.85 and down -34.0% over the past 90 days, while the company is unprofitable with a -53.5% annual revenue decline and net income of $-7.9M. Loren's cross-ticker track record shows 2 prior open-market buys with a 100% 90-day win rate and average 90-day return of +499.8%, and his prior trades at this specific ticker (2024 and 2025) were both well-timed with strong 90-day returns, though his most recent XELB purchase on 2025-08-04 has delivered only +33.6% over 30 days. The current purchase arrives at a depressed absolute price level following sharp recent declines, warranting attention to whether this reflects conviction in a recovery or a structural deterioration that insider buying cannot reverse.
Director DiSanto Mark bought 91.8K shares of XELB at $1.10, doubling position to 163.6K shares amid -86.1% decline from 52-week high.
Director DiSanto Mark purchased 91,800 shares at $1.10 on 2025-08-04, increasing his holdings from 71,783 to 163,583 shares (a +127.9% increase in share count). The transaction occurs at a price significantly below the 52-week high of $8.15, with the stock currently trading at $1.13, down -26.1% over 30 days and -52.3% over 90 days. Notably, his only prior purchase at this ticker on 2024-03-15 produced a 90-day return of +985.1%, suggesting past timing acuity. However, this must be weighed against fundamental deterioration: the company reported a net loss of $-2.8M last quarter on revenue of $1.3M, with annual revenue declining -53.5% year-over-year and an unprofitable full fiscal year. The purchase magnitude and price level relative to recent history warrant attention to whether this represents conviction or reflects valuation-driven opportunism in a distressed equity.
CEO Robert Loren bought 124,200 shares of XELB at $1.10 on 2025-08-04; stock down -86.1% from 52-week high, company unprofitable with -53.5% revenue decline
Robert Loren, CEO and Chairman, purchased 124,200 shares at $1.10, increasing his holdings by 36.0% to 469,044 shares. This open-market buy occurs in a severely distressed context: XCel Brands stock has declined 86.1% from its 52-week high and is down 52.3% over 90 days, while the company reported negative net income of $-2.8M in its latest quarter and annual revenue contracted 53.5% year-over-year. His prior buy at this same ticker on 2024-03-15 achieved a 90-day return of +985.1%, suggesting he has demonstrated timing ability at XELB specifically. The current purchase at $1.10 represents either recognition of intrinsic value after a sharp decline, or entry into a continued deterioration of an unprofitable business with eroding revenues.
Add XELB to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.